Month: November 2020

No Picture
Trading Ideas

Why Beauty Is in the Eye of the Bondholder

November 7, 2020 admin Comments Off on Why Beauty Is in the Eye of the Bondholder

It’s time we talked about the “B” word…
Bond.
These investment vehicles have a stodgy reputation.
But day trading detractors can laugh all they want…
In the meantime, corporate bondholders can collect legally guaranteed yields that often beat out blue chip stocks.
Consider this… Chief Income Strategist Marc Lichtenfeld has never lost money on a bond.
He has also never recommended a bond that has lost money.
So bonds may not get the glory – but they almost always win.
That’s why they’re a critical part of any income investor’s portfolio.
And in this week’s episode of the trailblazing YouTube series State of the Market, Marc shows you exactly …read more […]

No Picture
Trading Ideas

Wall Street Wants to Be Sure Biden Can Keep Warren’s Army at Bay

November 7, 2020 admin Comments Off on Wall Street Wants to Be Sure Biden Can Keep Warren’s Army at Bay

(Bloomberg) — Wall Street has made its peace with a Joe Biden victory, taking comfort in his decades-long political career in which moderation is a prevailing trait. But it’s nervous about his more liberal allies.Finance executives will be closely watching how Biden handles the coming internal Democratic fight between centrists and progressives that threatens to increase regulation and dent profits.Firms are counting on his business-friendly inner circle — a group that includes long-time Democratic stategists, corporate lawyers and former lobbyists — to exert the most influence in selecting nominees for agencies like the Treasury Department and the Securities and Exchange …read more […]

No Picture
Trading Ideas

Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In

November 7, 2020 admin Comments Off on Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In

The votes have been counted, and a decision has been rendered — no, not on the winner of the U.S. Presidential election (unfortunately), but on Biogen’s (BIIB) aducanumab Alzheimer’s drug.By a vote of one for, eight against, and two abstaining, the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee concluded Friday that positive clinical data from Biogen’s “EMERGE” trial, when “viewed independently and without regard for” data from the company’s “ENGAGE” trial, were not sufficient to convince it that aducanumab is an effective treatment for Alzheimer’s.The Advisory Committee furthermore voted zero to seven …read more […]

No Picture
Trading Ideas

How Do You Trade Volatility? What You Need to Know

November 7, 2020 admin Comments Off on How Do You Trade Volatility? What You Need to Know

How do you trade volatility? More and more people want to know the answer to this question. The stock market is a volatile place. It has big drops such as the dotcom bubble, housing market crisis and, most recently, the coronavirus. And that scares a lot of investors. But it shouldn’t worry you. Here we’ll go over some ways you can trade volatility.
But first…
What is Volatility?

Price volatility is the change in a security or market’s price over a given time period. The more a price or index moves, the higher the volatility. And the higher the volatility, the higher the …read more […]

No Picture
Trading Ideas

Berkshire operating results fall even as Apple boosts profit

November 7, 2020 admin Comments Off on Berkshire operating results fall even as Apple boosts profit

Berkshire said operating profit fell 32% to $5.48 billion from $8.07 billion a year earlier. Net income rose 82% to $30.14 billion, or $18,994 per Class A share, from $16.52 billion, or $10,119 per share, a year earlier. Berkshire’s share price is lagging the Standard & Poor’s 500 for a second straight year despite outperforming from July to September. …read more […]